फलो गर्नुहोस्
Englishनेपाली
← पछाडि

Monocef 250mg Injection

जेनेरिक: Ceftriaxone 250mg
Injection250mg५२ ब्रान्ड · २० निर्माता
Monocef 250 भनेको Ceftriaxone 250mg हो। यो Aristo Pharmaceuticals Ltd. ले बनाएको ब्रान्ड उत्पादन हो। यो नेपालमा vial of 2 ml Injection प्याकमा उपलब्ध छ। Monocef 250 NepalDoc सूचीमा रहेका Aristo Pharmaceuticals Ltd. का १२ वटा Monocef उत्पादनमध्ये एक हो।
ब्रान्ड (Brand)Monocef 250
सामान्य नाम (Generic name)Ceftriaxone
निर्माता (Maker)Aristo Pharmaceuticals Ltd.
रूप (Form)Injection
शक्ति (Strength)250mg
प्याक (Pack size)vial of 2 ml Injection
स्रोतNepalDoc medicine catalog

Monocef परिवार

Monocef Aristo Pharmaceuticals Ltd. को ब्रान्ड परिवार हो, नेपालमा बिक्री हुन्छ। NepalDoc सूचीमा यसका १२ वटा उत्पादन छन् — २ वटा औषधि लाइनमा: Ceftriaxone, Cefpodoxime proxetil।

Monocef 1gm InjectionCeftriaxone · 1gm
Monocef 125mg InjectionCeftriaxone · 125mg
Monocef 250mg Injection (यो पृष्ठ)Ceftriaxone · 250mg
Monocef 2gm InjectionCeftriaxone · 2gm
Monocef 500mg InjectionCeftriaxone · 500mg
Monocef O 25mg DropCefpodoxime proxetil · 25mg
Monocef-O 100mg TabletCefpodoxime proxetil · 100mg
Monocef-O 100 DT 100mg DT TabletCefpodoxime proxetil · 100mg
Monocef-O 100 Powder for 100mg SuspensionCefpodoxime proxetil · 100mg
Monocef-O 200mg TabletCefpodoxime proxetil · 200mg
Monocef-O 50mg SuspensionCefpodoxime proxetil · 50mg
Monocef-O Kid 50mg TabletCefpodoxime proxetil · 50mg

के का लागि

Before instituting treatment with ceftriaxone, appropriate specimens should be obtained for isolation of the causative organism and for determination of its susceptibility to the drug. Therapy may be instituted prior to obtaining results of susceptibility testing.

From the U.S. FDA-approved label for Ceftriaxone. Full label: DailyMed.

Before instituting treatment with ceftriaxone, appropriate specimens should be obtained for isolation of the causative organism and for determination of its susceptibility to the drug. Therapy may be instituted prior to obtaining results of susceptibility testing. To reduce the development of drug-resistant bacteria and maintain the effectiveness of ceftriaxone for injection, USP and other antibacterial drugs, ceftriaxone for injection, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Ceftriaxone for injection, USP is indicated for the treatment of the following infections when caused by susceptible organisms: Lower Respiratory Tract Infections Caused by Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Escherichia coli, Enterobacter aerogenes, Proteus mirabilis or Serratia marcescens.

From the U.S. FDA-approved label for Ceftriaxone. Full label: DailyMed.

Ceftriaxone may be administered intravenously or intramuscularly. Precipitation of ceftriaxone-calcium can also occur when ceftriaxone is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone must not be administered simultaneously with calcium-containing IV solutions, including continuous calcium-containing infusions such as parenteral nutrition via a Y-site.

Directions from the U.S. FDA-approved label for Ceftriaxone — your doctor or pharmacist may advise differently.

Hypersensitivity Ceftriaxone for injection is contraindicated in patients with known hypersensitivity to ceftriaxone, any of its excipients or to any other cephalosporin. Patients with previous hypersensitivity reactions to penicillin and other beta lactam antibacterial agents may be at greater risk of hypersensitivity to ceftriaxone (see Warnings – Hypersensitivity Reactions ). Neonates Premature neonates: Ceftriaxone for injection is contraindicated in premature neonates up to a post-menstrual age of 41 weeks (gestational age + chronological age).

Excerpt from the U.S. FDA-approved label for Ceftriaxone. Talk to a pharmacist or doctor before use.

Hypersensitivity Reactions Before therapy with ceftriaxone for injection is instituted, careful inquiry should be made to determine whether the patient has had previous hypersensitivity reactions to cephalosporins, penicillins and other beta-lactam agents or other drugs. This product should be given cautiously to penicillin and other beta-lactam agent-sensitive patients. Antibacterial drugs should be administered with caution to any patient who has demonstrated some form of allergy, particularly to drugs.

Warnings and precautions excerpt from the U.S. FDA-approved label for Ceftriaxone — not a complete list. Talk to a pharmacist or doctor before use.

Ceftriaxone is generally well tolerated. In clinical trials, the following adverse reactions, which were considered to be related to ceftriaxone therapy or of uncertain etiology, were observed: Local Reactions Pain, induration and tenderness was 1% overall. Phlebitis was reported in <1% after IV administration.

Excerpt from the U.S. FDA-approved label for Ceftriaxone — not a complete list. Talk to a pharmacist or doctor about side effects.

Accuzon 1g 1000mg InjectionMacleods Pharmaceuticals Pvt. Ltd.
Accuzon 250mg InjectionMacleods Pharmaceuticals Pvt. Ltd.
Accuzon 500mg InjectionMacleods Pharmaceuticals Pvt. Ltd.
Afrixon 2gm InjectionM.J. BIOPHARM PL LTD.
Blutax 1gm InjectionBlue Cross Laboratories Pvt. Ltd.
Cefast 1gm InjectionAkums Drugs And Pharmaceuticals Ltd.
Cefast 125mg InjectionAkums Drugs And Pharmaceuticals Ltd.
Controx 1gm InjectionConcept Pharmaceuticals Ltd.
Curaxone 1gm InjectionClaris Lifesciences Ltd

५२ ब्रान्ड · २० निर्माता — NepalDoc सूचीमा — पूरै Ceftriaxone गाइड हेर्नुहोस् →

Prior to Reconstitution Store at 20° to 25°C (68° to 77°F). Protect from light.

Storage information from the U.S. FDA-approved label for Ceftriaxone.

प्रश्न–उत्तर

Monocef 250 के हो?

Monocef 250mg Injection भनेको Ceftriaxone औषधि हो, Aristo Pharmaceuticals Ltd. ले बनाएको। यो 250mg Injection रूपमा पाइन्छ।

Monocef 250 को सामान्य नाम के हो?

Monocef 250 को सामान्य नाम Ceftriaxone हो।

नेपालमा Ceftriaxone का कुन कुन ब्रान्ड उपलब्ध छन्?

NepalDoc सूचीमा Ceftriaxone का ५२ वटा ब्रान्ड छन्, २० निर्माताबाट — जसमा Accuzon 1g 1000mg Injection, Accuzon 250mg Injection, Accuzon 500mg Injection, Afrixon 2gm Injection, Blutax 1gm Injection, Cefast 1gm Injection पर्छन्।

Monocef 250 को मूल्य नेपालमा कति हो?

NepalDoc ले औषधिको मूल्य सूचीबद्ध गर्दैन। मूल्य हरेक फार्मेसीले आफैं तय गर्छ र समयसँगै परिवर्तन हुन्छ — यो पृष्ठले नेपालमा बिक्री हुने ब्रान्ड, यसको सामान्य नाम, निर्माता, शक्ति र प्याक विवरण पुष्टि गर्छ, ताकि तपाईं आफ्नो फार्मेसीमा मूल्य विश्वस्त भएर सोध्न सक्नुहोस्।

पूर्ण औषधि गाइड औषधि बोर्डमा जाँच गर्नुहोस्
+ Safety information

यो पृष्ठ सामान्य जानकारीका लागि मात्र हो, चिकित्सकीय सल्लाह होइन। औषधिको विवरण माथि उल्लेखित स्रोतहरूबाट आएको हो र परिवर्तन हुन सक्छ — प्रयोग गर्नुअघि डाक्टर वा फार्मासिस्टसँग औषधि, शक्ति र मात्रा पुष्टि गर्नुहोस्। सूचीमा हुनुले कुनै फार्मेसीमा औषधि उपलब्ध छ भन्ने ग्यारेन्टी दिँदैन।

यो सेयर गर्नुहोस्
NepalDoc — Nepal's Healthcare Super-App (Beta) / नेपालको स्वास्थ्य सुपर-एप (बेटा).
Medicine information only — not medical advice. Confirm with a pharmacist or doctor.
No prices are shown — NepalDoc lists medicine information only.